Heterogeneous Cardiovascular Effects of SGLT2 Inhibitors in Type 2 Diabetes: A Causal Forest and Target Trial Emulation Study

By afschroeder • September 2, 2025

Mori Y, Komura T, Adomi M, Yagi R, Fukuma S, Kawakami K, Kondo N, Tsugawa Y, Yabe D, Yanagita M, Inoue K. Heterogeneous Cardiovascular Effects of SGLT2 Inhibitors in Type 2 Diabetes: A Causal Forest and Target Trial Emulation Study. Eur J Prev Cardiol. 2025 Sep 1:zwaf539. doi: 10.1093/eurjpc/zwaf539. Epub ahead of print. PMID: 40889271.

Tags: General Internal Medicine, Publications

Primary Cardiac Angiosarcoma Leading to Tamponade and Fatal Right Atrial Rupture

Makaroff KE, Hampilos K, Sayed S, Emert B, Hu X, Nsair A, Kwon M, Middlekauff H. Primary Cardiac Angiosarcoma Leading to Tamponade and Fatal Right[...]

Long COVID Persistence and Surveillance Gaps Across 58 US Hospitals

Tian J, Azhir A, Decaro M, Chau N, Hügel J, Morris M, Cheng J, Fard P, Bassett IV, Bell DS, Bernstam EV, Visweswaran S, Klann[...]

Use of Evidence-Based Type 2 Diabetes Preventive Therapies and Rates of Progression to Diabetes Among Veterans with Prediabetes by Race and Ethnicity, 2010-2019

Ly DP, Washington DL, Shekelle PG, Lee ML, Moin T. Use of Evidence-Based Type 2 Diabetes Preventive Therapies and Rates of Progression to Diabetes Among[...]